According to recent reports, RAF1 was overexpressed in a variety of cancers and down-regulation of RAF1 inhibited cancer progression [23-26], which means targeting RAF1 may be a promising strategy to interrupt cancer cell growth. Here, RAF1 is linked to cancer.